Literature DB >> 23907396

Mutations in hepatitis C virus p7 reduce both the egress and infectivity of assembled particles via impaired proton channel function.

Matthew J Bentham1, Toshana L Foster1, Christopher McCormick2, Stephen Griffin1.   

Abstract

Hepatitis C virus (HCV) p7 protein is critical for the efficient production of infectious virions in culture. p7 undergoes genotype-specific protein-protein interactions as well as displaying channel-forming activity, making it unclear whether the phenotypes of deleterious p7 mutations result from the disruption of one or both of these functions. Here, we showed that proton channel activity alone, provided in trans by either influenza virus M2 or genotype 1b HCV p7, was both necessary and sufficient to restore infectious particle production to genotype 2a HCV (JFH-1 isolate) carrying deleterious p7 alanine substitutions within the p7 dibasic loop (R33A, R35A), and the N-terminal trans-membrane region (N15 : C16 : H17/AAA). Both mutations markedly reduced mature p7 abundance, with those in the dibasic loop also significantly reducing levels of mature E2 and NS2. Interestingly, whilst M2 and genotype 1b p7 restored the same level of intracellular infectivity as JFH-1 p7, supplementing with the isogenic protein led to a further increase in secreted infectivity, suggesting a late-acting role for genotype-specific p7 protein interactions. Finally, cells infected by viruses carrying p7 mutations contained non-infectious core-containing particles with densities equivalent to WT HCV, indicating a requirement for p7 proton channel activity in conferring an infectious phenotype to virions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23907396     DOI: 10.1099/vir.0.054338-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy.

Authors:  Joseph Shaw; Rajendra Gosain; Monoj Mon Kalita; Toshana L Foster; Jayakanth Kankanala; D Ram Mahato; Sonia Abas; Barnabas J King; Claire Scott; Emma Brown; Matthew J Bentham; Laura Wetherill; Abigail Bloy; Adel Samson; Mark Harris; Jamel Mankouri; David J Rowlands; Andrew Macdonald; Alexander W Tarr; Wolfgang B Fischer; Richard Foster; Stephen Griffin
Journal:  Elife       Date:  2020-11-10       Impact factor: 8.140

2.  The intraviral protein interaction network of hepatitis C virus.

Authors:  Nicole Hagen; Karen Bayer; Kathrin Rösch; Michael Schindler
Journal:  Mol Cell Proteomics       Date:  2014-05-05       Impact factor: 5.911

3.  Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.

Authors:  Mounavya Aligeti; Allison Roder; Stacy M Horner
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

4.  NS2 is dispensable for efficient assembly of hepatitis C virus-like particles in a bipartite trans-encapsidation system.

Authors:  Matthew J Bentham; Najat Marraiki; Christopher J McCormick; David J Rowlands; Stephen Griffin
Journal:  J Gen Virol       Date:  2014-07-14       Impact factor: 3.891

5.  Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway.

Authors:  Issac Horng Khit Too; Huimin Yeo; October Michael Sessions; Benedict Yan; Eshele Anak Libau; Josephine L C Howe; Ze Qin Lim; Shalini Suku-Maran; Wei-Yi Ong; Kaw Bing Chua; Boon Seng Wong; Vincent T K Chow; Sylvie Alonso
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

6.  The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.

Authors:  Solène Denolly; Chloé Mialon; Thomas Bourlet; Fouzia Amirache; François Penin; Brett Lindenbach; Bertrand Boson; François-Loïc Cosset
Journal:  PLoS Pathog       Date:  2017-12-18       Impact factor: 6.823

7.  The Infectious Bronchitis Coronavirus Envelope Protein Alters Golgi pH To Protect the Spike Protein and Promote the Release of Infectious Virus.

Authors:  Jason W Westerbeck; Carolyn E Machamer
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 8.  Hepatitis C Virus Structure: Defined by What It Is Not.

Authors:  Altaira D Dearborn; Joseph Marcotrigiano
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 6.915

Review 9.  Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin.

Authors:  Vanesa Madan; Ralf Bartenschlager
Journal:  Viruses       Date:  2015-08-06       Impact factor: 5.048

10.  Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargement.

Authors:  Xiaobing Duan; Muhammad Ikram Anwar; Zhanxue Xu; Ling Ma; Guosheng Yuan; Yiyi Chen; Xi Liu; Jinyu Xia; Yuanping Zhou; Yi-Ping Li
Journal:  Emerg Microbes Infect       Date:  2018-08-08       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.